Smoking

Psychiatry·MeSH: Smoking Cessation

12 drugs in development·11 companies·17 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
exforge hct	Novartis AG (NVS)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
telmisartan	Inventiva S.A. (IVA)
varenicline	DR REDDYS LABORATORIES LTD (RDY)

Phase 3(1)

Drug	Company
cytisinicline	ACHIEVE LIFE SCIENCES, INC. (ACHV)

Phase 2(4)

Drug	Company
Brenipatide	ELI LILLY & Co (LLY)
Kava	Crinetics Pharmaceuticals, Inc. (CRNX)
Varenicline	Merus N.V. (MRUS)
Varenicline 0.5 MG	Merus N.V. (MRUS)

Preclinical(1)

Drug	Company
skny-1	MIRA PHARMACEUTICALS, INC. (MIRA)

BioSniper tracks 12 drugs in development for Smoking across 11 companies.

There are 17 clinical trials targeting Smoking tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.